Trial
NCT00540995
Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
City of Hope Medical Center
Collaborators
—
Condition
Adult Acute Myeloid Leukemia in Remission
Intervention
busulfan
Why stopped
Unable to safely escalate to TMLI doses that were hypothesized to be effective and less toxic than FTBI. Likely due to the giving of Busulfan prior to radiation delivery. Therefore, the study was abandoned and no further patients were accrued.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-11-30